LightDeck Diagnostics Inc (LightDeck) is a medical device company that offers clinical diagnostics and sample testing solutions. The company offers MBio multiplex analyzer and disposable cartridges. Its LightDeck Array System is a fluorescence immunoassay system that provides measurement of analytes from a single sample. The company’s products are used in clinical and analytical testing applications across medical, veterinary, agricultural, environmental, food, and military markets. It operates biosafety laboratories in Boulder for biological assay development, method development and validation. LightDeck is headquartered in Boulder, Colorado, the US..
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company LightDeck Diagnostics Inc
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company
LightDeck Diagnostics Inc Company Overview
LightDeck Diagnostics Inc Company Snapshot
LightDeck Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
LightDeck Diagnostics Inc - Locations And Subsidiaries
Head Office
Recent Developments
LightDeck Diagnostics Inc, Recent Developments
Jan 26, 2022: LightDeck Diagnostics and The Henry M. Jackson Foundation for the Advancement of Military Medicine receive $2M to develop rapid, multiplexed inflammation test
Jul 21, 2021: LightDeck Diagnostics Appoints Nick Traggis as CEO to Scale Company Operations Through Next Phase of Growth
Jul 08, 2021: DOD, HHS awards a $35.1M contract to LightDeck Diagnostics to increase production of its 5-Minute point-of-care tests for COVID-19
Feb 21, 2021: LightDeck Diagnostics awarded $5.65 million from BARDA to develop a rapid antigen test for SARS-CoV-2
Nov 20, 2020: LightDeck Diagnostics earns certification to ISO 13485:2016 / MDSAP, affirming excellence in company’s quality management system
Jun 23, 2020: MBio Diagnostics and BARDA partner on a 5-minute, Quantitative Point-of-Care COVID-19 Antibody Panel
Jun 15, 2020: MBio delivers rapid cytokine test system for COVID-19 research
Apr 06, 2020: MBio to seek FDA approval for LightDeck platform
Jan 26, 2020: Brava Diagnostics to present at Rockies Venture Club Demo Day
Jan 14, 2020: MBio Diagnostics announces new contracts with SRI